177 related articles for article (PubMed ID: 25098924)
1. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study.
Higuchi K; Takeuchi T; Uedo N; Takeuchi Y; Naito Y; Yagi N; Tominaga K; Machida H; Tamada T; Morita Y; Yazumi S; Yamao J; Iguchi M; Azuma T
Gastric Cancer; 2015 Jul; 18(3):612-7. PubMed ID: 25098924
[TBL] [Abstract][Full Text] [Related]
2. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
[TBL] [Abstract][Full Text] [Related]
3. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.
Takayama M; Matsui S; Kawasaki M; Asakuma Y; Sakurai T; Kashida H; Kudo M
World J Gastroenterol; 2013 Sep; 19(34):5706-12. PubMed ID: 24039365
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
Xiong J; Lai S; Zhang P; Li Q; Wei Y; Yang Y; Wang T; Liu L; Ma X; Chen D
Medicine (Baltimore); 2014 Sep; 93(12):e64. PubMed ID: 25211045
[TBL] [Abstract][Full Text] [Related]
8. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
[TBL] [Abstract][Full Text] [Related]
9. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Nakamura K; Ihara E; Akiho H; Akahoshi K; Harada N; Ochiai T; Nakamura N; Ogino H; Iwasa T; Aso A; Iboshi Y; Takayanagi R
Gut Liver; 2016 Nov; 10(6):917-924. PubMed ID: 27282261
[TBL] [Abstract][Full Text] [Related]
10. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
Takahashi Y; Takeuchi T; Kojima Y; Nagami Y; Ominami M; Uedo N; Hamada K; Suzuki H; Oda I; Miyaoka Y; Yamanouchi S; Tokioka S; Tomatsuri N; Yoshida N; Naito Y; Nonaka T; Kodashima S; Ogata S; Hongo Y; Oshima T; Li Z; Shibagaki K; Oikawa T; Tominaga K; Higuchi K
J Gastroenterol Hepatol; 2018 Jul; 33(7):1341-1346. PubMed ID: 29265496
[TBL] [Abstract][Full Text] [Related]
12. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
[TBL] [Abstract][Full Text] [Related]
13. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study.
Kato T; Araki H; Onogi F; Ibuka T; Sugiyama A; Tomita E; Nagaki M; Moriwaki H
J Gastroenterol; 2010 Mar; 45(3):285-90. PubMed ID: 19957195
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
Fujiwara S; Morita Y; Toyonaga T; Kawakami F; Itoh T; Yoshida M; Kutsumi H; Azuma T
J Gastroenterol; 2011 May; 46(5):595-602. PubMed ID: 21359522
[TBL] [Abstract][Full Text] [Related]
16. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis.
Wang J; Guo X; Ye C; Yu S; Zhang J; Song J; Cao Z; Wang J; Liu M; Dong W
Intern Med; 2014; 53(12):1243-8. PubMed ID: 24930641
[TBL] [Abstract][Full Text] [Related]
18. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
[TBL] [Abstract][Full Text] [Related]
20. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Fujioka T; Arakawa T; Shimoyama T; Yoshikawa T; Itoh M; Asaka M; Ishii H; Kuwayama H; Sato R; Kawai S; Takemoto T; Kobayashi K
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():146-52. PubMed ID: 12925153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
